1 |
Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study |
|
|
| Saurabh Gupta, Syed A Zaki, Sanjeevani Masavkar, Preeti Shanbag |
|
| Cureus. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Meropenem-Induced Resistant Hypokalemia |
|
|
| Jennifer Anne Glover, Farjana Alam, Salil Avasthi, Deepti Avasthi |
|
| Infectious Diseases in Clinical Practice. 2020; 28(6): e36 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Urinary tract infection is associated with hypokalemia: a case control study |
|
|
| Ai-Ling Shen, Hsiu-Li Lin, Hsiu-Chen Lin, Yuan-Fu Tseng, Chien-Yeh Hsu, Che-Yi Chou |
|
| BMC Urology. 2020; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use |
|
|
| Pragyan Swagatika Panda, Surya Kumar Dube, Suman Sarkar, Dinesh Kumar Singh |
|
| Indian Journal of Critical Care Medicine. 2013; 17(4): 263 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Two cases of meropenem-induced severe bullous drug eruptions and the literature analysis |
|
|
| Xu, J., Li, T.-Y., Xu, J., Lu, X., Liao, Q.-C. |
|
| Chinese Journal of New Drugs. 2013; 22(18): 2219-2222 |
|
| [Pubmed] [Google Scholar] |
|
6 |
Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastatin use |
|
|
| Panda, P.S., Dube, S.K., Sarkar, S., Singh, D.K. |
|
| Indian Journal of Critical Care Medicine. 2013; 17(4): 263-263 |
|
| [Pubmed] [Google Scholar] |
|